Form 4 Filing for Marwan Sabbagh - Stock Option Grant

This filing details a Form 4 filing by Marwan Sabbagh concerning CervoMed Inc. (CRVO). On June 8, 2026, Mr. Sabbagh, a newly elected director, was granted a stock option to purchase 8,150 shares of the company's common stock. This grant, made under the 2025 Equity Incentive Plan, is part of the non-employee director compensation policy. The option has an exercise price of $2.91 and an expiration date of June 8, 2036. The shares underlying the option will vest monthly over one year, starting June 30, 2026, contingent upon continued service. Mr. Sabbagh acquired these options directly, and following this transaction, he directly owns 8,150 shares.